Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
All India Institute of Medical Sciences, Bhubaneswar
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Schizophrenia patients who are diagnosed as treatment-resistant schizophrenia (TRS) defined as having been tried and not responded to any two antipsychotic medication for a duration of 6 weeks with dose equivalent of 600 mg of chlorpromazine and initiated on clozapine for the treatment of the same.
The patients who are on stable dose of clozapine.
Patients of either sex with age \>18 years.
Patients for whom legally authorized representative (LAR) are willing to give informed consent.
You may not be if
Patients with significant medical comorbidity.
Patients with significant psychiatric comorbidity.
Patients having active substance abuse history during the time of screening.
Female patients who are pregnant or in reproductive age not using contraception.
Female patients who are breast feeding
Clareo Health | Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia
